🔒 Closed Bagong gamot daw sa covid

Status
Not open for further replies.
He he. Sa ngayon po sa PH, +92% po ang recovery rates, 1.9% ang fatality rate, at 92% din yung natitirang mild to asymptomatic cases. Dyan pa lang ay ok naman yung kasalukang medical treatment procedures nating sinusunod. Yung mild cases, paracetamol, good diet, at pahinga lang ang kailangan. Pero kung totoo at i-apruba yan ng WHO/FDA ay wala namang masama siguro. Kung may prophylactic use yan ay mas mainam, dahil ang main objective ng lahat ay to "prevent infection", di po ba?

...Under continuous clinical trial po yang ivermectin in combination with other drugs as part of our quest for an effective COVID-19 drug treatment side-by-side with vaccine development. Intayin na lang po natin kung makapasa yan o hindi. Ganyan po talaga ang proseso.

Parang dexamethasone ( a corticosteroid ) din yan na pinagdududahan noon pero pinagtitiwalaan ngayon. Yung latest revised guidelines ng WHO (Dec. 17, 2020), ito na yung recommendation:
You do not have permission to view the full content of this post. Log in or register now.
You do not have permission to view the full content of this post. Log in or register now.

Current practice: Current practice to treat COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This version of the WHO Therapeutics and COVID-19: living guideline contains new information and recommendations on hydroxychloroquine and lopinavir/ritonavir. It follows the preprint publication of results from the WHO SOLIDARITY trial on 15 October 2020 (1) and a peer-reviewed publication on 1 December 2020 (2), which also reported results on remdesivir and interferonbeta.
Recommendations: The panel made strong recommendations against the use of hydroxychloroquine and lopinavir/ritonavir in patients with COVID-19, regardless of disease severity. This guidance adds to recommendations published in the previous version with: • a strong recommendation for systemic corticosteroids in patients with severe and critical COVID-19; • a conditional recommendation against systemic corticosteroids in patients with non-severe COVID-19; and • a conditional recommendation against remdesivir in hospitalized patients with COVID-19....
Medyo kakaiba base sa past statements nila nang nilabas yung list ng solidarity trials. Taliwas din sa US FDA na approved as antiviral drug yung Giliad's Veklury (Remdevisir).
You do not have permission to view the full content of this post. Log in or register now.
....It's up to our gov't to follow which one proves effective for us.
 
matagal na yan news, edi sana na test na yan.
He he. Right. At dapat din alamin ng tao yung effect of previously MMR II vaccinated (COVID-19) patients (when they were 1yr. old and above) vs. COVID-19 severity,
( You do not have permission to view the full content of this post. Log in or register now. )
related sa high rates of "immune to asymptomatic cases", at yung cross-immunity imparted by the HCoVs (betacoronaviruses HCoV-OC43 and HCoV-HKU1, atbp.
( You do not have permission to view the full content of this post. Log in or register now. )
na endemic na HCoVs sa maraming lugar sa mundo including Asia. Kung di pa alam ng karamihan, meron ng HCoV-OC43 and HCoV-NL63 (alphacoronavirus) cases sa Tacloban City conducted on May 2008 to May 2009,
( You do not have permission to view the full content of this post. Log in or register now. )
You do not have permission to view the full content of this post. Log in or register now. )
Since then wala pang studies na tinuloy tungkol dyan sa ating bansa, except w/ foreign experts assistance.
And since 2008 or even before ay may evidence ng iba't ibang klaseng mga coronaviruses sa ating kagubatan tulad ng mga galing sa paniki - bat coronaviruses or BtCoVs.
( You do not have permission to view the full content of this post. Log in or register now. )
There is a plausible study of partial/temporary immunity/protection too kung sakali sa mga HCoV pre-infected patients kaya maraming asymptomatic-mild cases din sa ibang panig ng mundo.
( You do not have permission to view the full content of this post. Log in or register now. )
It may not be a cure or exact science to be happy about, but a form of relief to know at the least. Karamihan sa Pinoy ay nabakunahan na ng MMR II (for measles, mumps, rubella) vaccine by Merck. Alam ng lahat na pangontra yan noon sa MERS.
These previous findings have high incidence and observed in many parts of the world, though it still needs further study.
Ang punto ko, kung mataas ang chance mong maging "asymptomatic-mild", di mo kailangang mag-alala. Iwasan mo lang makahawa after more than 2 weeks para sigurado! Makes sense?
 
Status
Not open for further replies.

About this Thread

  • 8
    Replies
  • 507
    Views
  • 7
    Participants
Last reply from:
alist1986

Trending Topics

Online now

Members online
1,237
Guests online
2,787
Total visitors
4,024

Forum statistics

Threads
2,271,040
Posts
28,938,992
Members
1,240,142
Latest member
z0d
Back
Top